Viking Therapeutics
VKTX
VKTX
407 hedge funds and large institutions have $2.42B invested in Viking Therapeutics in 2026 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 155 increasing their positions, 115 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
4% less first-time investments, than exits
New positions opened: 67 | Existing positions closed: 70
4% less capital invested
Capital invested by funds: $2.53B → $2.42B (-$109M)
4% less funds holding
Funds holding: 422 → 407 (-15)
Holders
407
Holding in Top 10
5
Calls
$241M
Puts
$71M
Top Buyers
| 1 | +$64.2M | |
| 2 | +$57M | |
| 3 | +$37.1M | |
| 4 |
VPC
Vestal Point Capital
New York
|
+$29.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.3M |
Top Sellers
| 1 | -$24.2M | |
| 2 | -$23.1M | |
| 3 | -$21M | |
| 4 |
AGP
Artia Global Partners
Miami,
Florida
|
-$17.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.1M |
